User profiles for Ricardo Cortés-Alcalá

Ricardo Cortes-Alcala

Secretaría de Salud México
Verified email at salud.gob.mx
Cited by 402

Prevalencia de anticuerpos y vacunación contra SARS-CoV-2 en 2022 en México

…, M Romero-Martínez, R Cortés-Alcalá… - salud pública de …, 2023 - saludpublica.mx
Objetivo. Describir la prevalencia de anticuerpos contra SARS-CoV-2, vacunación, barreras
y rechazo a la vacunación Covid-19 en población mexicana. Material y métodos. Se utilizó …

[HTML][HTML] Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study

…, G García-Rodríguez, R Cortés-Alcalá… - The Lancet Regional …, 2023 - thelancet.com
Background Human monkeypox, a zoonosis historically endemic to West and South Africa,
has led to a worldwide outbreak driven by human-to-human transmission resulting in an …

The association of obesity, type 2 diabetes, and hypertension with severe coronavirus disease 2019 on admission among Mexican patients

…, DD Dyer‐Leal, R CortésAlcala… - …, 2020 - Wiley Online Library
Objective This study’s aim was to explore the association of obesity, type 2 diabetes, and
hypertension with severe coronavirus disease 2019 (COVID‐19) on admission. Methods In the …

[HTML][HTML] Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020–2021: A death certificates study in a middle-income country

…, M Alvarez-Aceves, R Cortés-Alcalá… - The Lancet Regional …, 2022 - thelancet.com
Background The death toll after SARS-CoV-2 emergence includes deaths directly or indirectly
associated with COVID-19. Mexico reported 325,415 excess deaths, 34.4% of them not …

Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines

…, JL Díaz‐Ortega, R CortesAlcalá… - European journal of …, 2022 - Wiley Online Library
Background and purpose Information on Guillain–Barré syndrome (GBS) as an adverse event
following immunization (AEFI) against SARS‐CoV‐2 remains scarce. We aimed to report …

[HTML][HTML] Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis …

…, G García-Rodríguez, R Cortés-Alcalá… - International Journal of …, 2023 - Elsevier
Objectives Vaccination has been effective in ameliorating the impact of COVID-19. Here, we
report vaccine effectiveness (VE) of the nationally available COVID-19 vaccines in Mexico. …

[HTML][HTML] Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines

…, G Sánchez-González, R Cortés-Alcalá… - Human Vaccines & …, 2018 - Taylor & Francis
… Rodrigo DeAntonio and Ricardo Cortes-Alcala were employees of the GSK group of
companies during the study. Ricardo Navarro, Gilberto Sanchez, Gerardo Luna and Andrés …

[HTML][HTML] Determinants of COVID-19 Vaccine Acceptance and Uptake in a Transborder Population at the Mexico–Guatemala Border, September–November 2021

…, M Arévalo, R Cortés-Alcalá… - International Journal of …, 2022 - mdpi.com
Assessing COVID-19 vaccination uptake of transborder populations is critical for informing
public health policies. We conducted a probability (time-venue) survey of adults crossing from …

Effectiveness of a nation-wide COVID-19 vaccination program in Mexico

…, G García-Rodríguez, R Cortés-Alcalá… - medRxiv, 2022 - medrxiv.org
BACKGROUND Vaccination has been effective in ameliorating the impact of COVID-19.
However, estimation of vaccine effectiveness (VE) is still unavailable for some widely used …

Stroke among SARS-CoV-2 vaccine recipients in Mexico: a nationwide descriptive study

…, E Gonzalez-Guerra, R Cortes-Alcala… - Neurology, 2022 - AAN Enterprises
Background and Objectives Information on stroke among severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines remains scarce. We report stroke incidence as an …